1Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25(2):279-286.
2Kobayashi N, DeLano FA, Schmid-Schonbein GW. Oxidative stress promotes endothelial cell apoptosis and loss of microvessels in the spontaneously hypertensive rats [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25(10) :2114 -2121.
3Virdis A, Neves MF, Amiri F, et al. Role of NAD (P) H oxidase on vascular alterations in angiotensin II-infused mice [ J ]. J Hypertens, 2004, 22(3) :535 -542.
4Wang B, Pan J, Wang L, et al. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease [ J ]. Atherosclerosis, 2006, 184 (2) :425 -430.
5Nobecourt E, Jacqueminet S, Hansel B, et al. Defective antioxidative activity of small dense HDL 3 particles in type 2 diabetes : relationship to elevated oxidative stress and hyperglycaemia [ J ]. Diabetologia, 2005,48(2) :529 -538.
6Flores L, Rodela S, Abian J, et al. F2 isoprostane is already increased at the onset of type 1 diabetes mellitus: effect of glycemic control[J]. Metabolism, 2004, 53(9) :1118 - 1120.
8Brownlee M. The pathobiology of diabetic complications: a unifying mechanism[J]. Diabetes, 2005, 54(6) :1615 - 1625.
9Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease [ J ]. Kidney Int, 2004, 65 ( 3 ) : 1009 - 1016.
10Dobrian AD, Schriver SD, Khraibi AA, et al. Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity [J]. Hypertension, 2004, 43( 1 ) :48 -56.
4Kobayashi A,Takahashi T,Sugai S,et al. Urinary excretion of oxidative metabolites of bilirubin in fenofibrate-treated rats[J]. J Toxicol Sci,2003,28(2):71-75.
5Bruner SD,Norman DP,Verdine GL. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA[J]. Nature,2000,403(6772):859-866.
6Makropoulos W,Kocher K,Heintz B,et al. Urinary thymidine glycol as a biomarker for oxidative stress after kidney transplantation[J]. Renal Failure,2000,22(4):499-510.
7Kneepkens CM,Lepage G,Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation[J]. Free Radic Biol Med,1994,17(2):127-160.
8McGrath LT,McGleenon BM,Brennan S,et al. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde[J]. Quarterly Journal of Medicine,2001,94(9):485-490.
9Cracowski JL,Durand T,Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans:physiology,pharmacology and clinical implications[J]. Trends Pharmacol Sci,2002,23(8):360-366.
10Feillet-Coudray C,Chone F,Michel F,et al. Divergence in plasmatic and urinary isoprostane levels in type 2 diabetes[J]. Clinica Chimica Acta,2002,324(1-2):25-30.
